Biopharma Layoff Tracker 2024. The top line sarepta therapeutics abbott fda approval. In the first quarter of 2023, 56 biopharmas laid off staff—an 87% jump over the same period in 2022, when 30 companies made cuts, according to a fierce biotech.
Biopharma layoffs rose 57% last year compared to 2022, with 187 industry workforce reductions in 2023 compared to 119, according to an analysis of fierce. Guarded optimism seems to be the mood of the biopharmaceutical industry to start 2024.
We Really Didn't Want To Have To Create Another Layoff Tracker This Year.
The top line sarepta therapeutics abbott fda approval.
The Reorganization Includes Cutting About.
But here we are, launching the third annual iteration tracking industry layoffs.
More Than 115 Biotech Companies Have Announced Layoffs This Year, On Track To Easily Surpass 2022’S Numbers.
Images References :
More Than 115 Biotech Companies Have Announced Layoffs This Year, On Track To Easily Surpass 2022’S Numbers.
In the first quarter of 2023, 56 biopharmas laid off staff—an 87% jump over the same period in 2022, when 30 companies made cuts, according to a fierce biotech.
Last Year, We Tallied 119 Total Layoffs Among Biotech Companies, With A Rush Of 23 Announced In November 2022.
The latest clutch of staff reductions that have kicked.
Will Lay Off About 30% Of Its Staff And Affimed Will.
